Skip to Content

CIBA LN (Metopirone 250 mg)

Generic Name: metyrapone

Pill with imprint CIBA LN is White, Capsule-shape and has been identified as Metopirone 250 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Metopirone is used in the treatment of diagnosis and investigation and belongs to the drug classes adrenal corticosteroid inhibitors, in vivo diagnostic biologicals. Risk cannot be ruled out during pregnancy. Metopirone 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CIBA LN

Metopirone 250 mg CIBA LN

Metopirone

Generic Name
metyrapone
Imprint
CIBA LN
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Adrenal corticosteroid inhibitors, In vivo diagnostic biologicals
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0455

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.